Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Dec 12, 2011
Boston Scientific's third new peripheral balloon catheter introduced in 2011 strengthens Company's position as a global leader in peripheral angioplasty balloons.
-
Dec 8, 2011World's first and only 16-contact percutaneous lead provides innovative, new option for physicians to treat chronic pain
Boston Scientific Corporation (NYSE: BSX) announces U.S. Food and Drug Administration (FDA) approval of the Infinion™ 16 Percutaneous...
-
Nov 30, 2011
Extended ICD/CRT-D program offers warranties up to 10 years
-
Nov 30, 2011
New family of cardiac devices offers excellent longevity and industry's longest warranty.
-
Nov 22, 2011
Approval marks transition to internally manufactured everolimus-eluting stent in the U.S.
-
Nov 18, 2011
Boston Scientific will participate in the healthcare conference on November 30, 2011. Learn how to watch the webcast or replay.
-
Nov 16, 2011
Innovative left atrial appendage closure device offers proven alternative to anticoagulant drugs for patients in atrial fibrillation at high risk for stroke.
-
Nov 15, 2011
Legislation seeks to improve the ability of companies like Boston Scientific to safely, efficiently and predictably bring new technologies to market.
-
Nov 11, 2011
Positive results from COBRA trial presented at TCT
-
Nov 11, 2011
EVOLVE trial evaluates fourth-generation everolimus-eluting coronary stent with ultra-thin abluminal bioabsorbable polymer.